2,4,6-Triisopropylbenzenesulfonyl chloride | CAS:6553-96-4

We serve 2,4,6-Triisopropylbenzenesulfonyl chloride CAS:6553-96-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4,6-Triisopropylbenzenesulfonyl chloride

Chemical Name:2,4,6-Triisopropylbenzenesulfonyl chloride
CAS.NO:6553-96-4
Synonyms:2,4,6-tri(propan-2-yl)benzenesulfonyl chloride;TPSCL
Molecular Formula:C15H23ClO2S
Molecular Weight:302.86000
 
Physical and Chemical Properties:
Density:1.096;
Melting point:92-94oC;
Boiling point:349.3oC;
Flash point:165.1oC;
Index of Refraction:1.505;
 
UN No.: UN3261
Hazard class: 8 categories 
Packing level: Class III
 
Specification:
Appearance:White powder
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent



Contact us for information like 2,4,6-Triisopropylbenzenesulfonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,TPSCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4,6-Triisopropylbenzenesulfonyl chloride Use and application,TPSCL technical grade,usp/ep/jp grade.


Related News: Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.2-Methyl-1-butanethiol manufacturer ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.(3R,4S)-3-Hydroxy-4-phenylazetidin-2-one supplier Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine,hydrochloride vendor Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.